original image from www.freefoto.com cvEpi - Collaboration & Resources for the Cardiovascular Epidemiology Community
About CV EPICollaborationTrainee ResearchTraining and CareerConferences & EventsEmployment
Trainee Research
 
Blood Pressure and Cardiovascular risk in women with prevalent cardiovascular disease or multiple cardiac risk factors

 


Peter J. Mason, JoAnn E. Manson, Marilyn J. Chown, Howard D. Sesso, Paul M. Ridker, Robert J. Glynn

Objective: Some studies suggest a J-shaped relationship between blood pressure and cardiovascular disease (CVD) risk in treated hypertensives and those with prior CVD. We examined the association of systolic blood pressure (SBP), diastolic blood pressure (DBP), pulse pressure (PP), and mean arterial pressure (MAP) with subsequent CVD events among high-risk women participating in the Women's Antioxidant and Cardiovascular Study (WACS).

Methods: WACS, double-blind, placebo-controlled, secondary prevention trial of the benefits and risks of antioxidant vitamins, randomized 8,171 women, including two strata: 5,951 women with prevalent CVD and 2,191 women with = 3 cardiac risk factors. At baseline, mean age was 60.6 years, mean SBP was 135.3 mmHg and mean DBP was 81.8 mmHg, among those reporting blood pressure at baseline (99.6%). The primary outcome measure was a combined endpoint of confirmed nonfatal MI, nonfatal stroke, coronary revascularization procedures (CABG or PTCA), and CVD mortality.

Results: To date 512 CVD events have been confirmed in this ongoing trial, with a median follow-up of 4.2 years. We used stratified proportional hazards models to examine the relationship of several components of blood pressure with cardiovascular risk, controlling for age, cigarette smoking, body mass index, elevated cholesterol, diabetes, alcohol use, menopause, level of exercise, and use of antihypertensive medications, We found no increased risk associated with low levels of either SBP or DBP. Based upon a comparison of likelihood ratios, SBP was a stronger predictor of CVD risk than DBP, PP or MAP. The relationship of SBP with CVD risk was not linear: below 140 mmHg there was no association with CVD risk. Compared to women with SBP of 120-129 mmHg, those with SBPs of 140-159 and = 160 mmHg had proportional hazard ratios of 1.22 (95% CI, 0.90-1.64) and 2.17 (95% CI, 1.49-3.14), respectively. Results were similar for the women with prevalent CVD and those with = 3 risk factors.

Conclusion: SBP, as compared to other measurements of blood pressure, is the strongest predictor of CVD risk among middle-aged women with known CVD and in women with multiple cardiac risk factors. There does not appear to be a J-shaped relationship between blood pressure and CVD risk in the WACS study population.

View Slides

     
Site development funded by the NHLBI
CVD Epidemiology Group - UNC Chapel Hill
Copyright 2001 - Site use statement